{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:38:15Z","timestamp":1791005895827,"version":"4.1.0"},"reference-count":29,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2024.12715","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T12:29:35Z","timestamp":1726057775000},"source":"Crossref","is-referenced-by-count":5,"title":["Myasthenia gravis and myocarditis induced by chemoimmunotherapy in locally advanced gastric cancer: A case report"],"prefix":"10.3892","volume":"28","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Oncology, Panjin Central Hospital, Panjin, Liaoning 124000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichang","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Oncology, Panjin Central Hospital, Panjin, Liaoning 124000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Panjin Central Hospital, Panjin, Liaoning 124000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 124000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 124000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaochu","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 124000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 124000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"issue":"e33550","key":"key20240927091432_b1-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033550","article-title":"Immune checkpoint inhibitor sintilimab-induced lethal myocarditis overlapping with myasthenia gravis in thymoma patient: A case report","volume":"102","author":"Wang","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"895187","key":"key20240927091432_b2-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.895187","article-title":"Efficacy and safety evaluation of sintilimab for cancer treatment: A systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Ye","year":"2022","journal-title":"Front Pharmacol"},{"key":"key20240927091432_b3-ETM-28-5-12715","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/onco.13931","article-title":"Immune checkpoint inhibitor-induced myocarditis with myositis\/myasthenia gravis overlap syndrome: A systematic review of cases","volume":"26","author":"Pathak","year":"2021","journal-title":"Oncologist"},{"key":"key20240927091432_b4-ETM-28-5-12715","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/art.41604","article-title":"Inflammatory myositis in cancer patients receiving immune checkpoint inhibitors","volume":"73","author":"Aldrich","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"933","key":"key20240927091432_b5-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30533-6","article-title":"Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis","volume":"391","author":"Moslehi","year":"2018","journal-title":"Lancet"},{"key":"key20240927091432_b6-ETM-28-5-12715","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"key20240927091432_b7-ETM-28-5-12715","doi-asserted-by":"publisher","first-page":"91","DOI":"10.31662\/jmaj.2021-0001","article-title":"Mechanisms and management of immune checkpoint inhibitor-related cardiac adverse events","volume":"4","author":"Kadowaki","year":"2021","journal-title":"JMA J"},{"key":"key20240927091432_b8-ETM-28-5-12715","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaccao.2020.11.012","article-title":"The evolving immunotherapy landscape and the epidemiology, diagnosis, and management of cardiotoxicity: JACC: CardioOncology primer","volume":"3","author":"Zhang","year":"2021","journal-title":"JACC CardioOncol"},{"key":"key20240927091432_b9-ETM-28-5-12715"},{"key":"key20240927091432_b10-ETM-28-5-12715"},{"key":"key20240927091432_b11-ETM-28-5-12715","doi-asserted-by":"crossref","first-page":"47","DOI":"10.15561\/26649837.2022.0106","article-title":"The effect of TRX suspension trainer and BOSU platform after reconstruction of anterior cruciate ligament of the knee joint","volume":"26","author":"Andrejeva","year":"2022","journal-title":"Pedagogy Phys Cult Sports"},{"issue":"103700","key":"key20240927091432_b12-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103700","article-title":"The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials","volume":"174","author":"Guven","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"issue":"423","key":"key20240927091432_b13-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2024.14556","article-title":"Rare primary intrapulmonary malignant peripheral nerve sheath tumor showing significant response to sintilimab: A case report and literature review","volume":"28","author":"Chen","year":"2024","journal-title":"Oncol Lett"},{"key":"key20240927091432_b14-ETM-28-5-12715","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"issue":"8","key":"key20240927091432_b15-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0316-z","article-title":"Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: A comprehensive review of registration trials and future considerations","volume":"6","author":"Gong","year":"2018","journal-title":"J Immunother Cancer"},{"key":"key20240927091432_b16-ETM-28-5-12715","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1212\/WNL.0000000000004359","article-title":"Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan","volume":"89","author":"Suzuki","year":"2017","journal-title":"Neurology"},{"key":"key20240927091432_b17-ETM-28-5-12715","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.2147\/CMAR.S247554","article-title":"Multiple immune-related adverse events and anti-tumor efficacy: Real-world data on various solid tumors","volume":"12","author":"Shimozaki","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"e32240","key":"key20240927091432_b18-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032240","article-title":"Immune checkpoint inhibitor-induced myocarditis with myasthenia gravis overlap syndrome: A case report and literature review","volume":"101","author":"Gao","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"e36446","key":"key20240927091432_b19-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36446","article-title":"Two cases of immune checkpoint inhibitor-induced myocarditis with complete atrioventricular block","volume":"15","author":"Kondo","year":"2023","journal-title":"Cureus"},{"key":"key20240927091432_b20-ETM-28-5-12715","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: A systematic review and meta-analysis","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol"},{"issue":"e004699","key":"key20240927091432_b21-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004699","article-title":"Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: Proof of concept","volume":"10","author":"Nguyen","year":"2022","journal-title":"J Immunother Cancer"},{"key":"key20240927091432_b22-ETM-28-5-12715","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.5858\/arpa.2019-0447-OA","article-title":"Histopathologic characterization of myocarditis associated with immune checkpoint inhibitor therapy","volume":"144","author":"Sobol","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"e7039","key":"key20240927091432_b23-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.7039","article-title":"Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report","volume":"11","author":"Zhong","year":"2023","journal-title":"Clin Case Rep"},{"key":"key20240927091432_b24-ETM-28-5-12715","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1158\/2159-8290.CD-20-0856","article-title":"A genetic mouse model recapitulates immune checkpoint inhibitor-associated myocarditis and supports a mechanism-based therapeutic intervention","volume":"11","author":"Wei","year":"2021","journal-title":"Cancer Discov"},{"issue":"682262","key":"key20240927091432_b25-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.682262","article-title":"Immune myocarditis overlapping with myasthenia gravis due to anti-PD-1 treatment for a chordoma patient: A case report and literature review","volume":"12","author":"Liang","year":"2021","journal-title":"Front Immunol"},{"issue":"518","key":"key20240927091432_b26-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-07987-x","article-title":"Improved outcomes with early immunosuppression in patients with immune-checkpoint inhibitor induced myasthenia gravis, myocarditis and myositis: A case series","volume":"31","author":"Weaver","year":"2023","journal-title":"Support Care Cancer"},{"key":"key20240927091432_b27-ETM-28-5-12715","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/CMR.0000000000000310","article-title":"Two cases of clinical myasthenia gravis associated with pembrolizumab use in responding melanoma patients","volume":"27","author":"Nguyen","year":"2017","journal-title":"Melanoma Res"},{"issue":"333","key":"key20240927091432_b28-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01904-4","article-title":"A rare case of nivolumab-related myasthenia gravis and myocarditis in a patient with metastatic gastric cancer","volume":"21","author":"Komatsu","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"803410","key":"key20240927091432_b29-ETM-28-5-12715","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.803410","article-title":"Incidence and distinct features of immune checkpoint inhibitor-related myositis from idiopathic inflammatory myositis: A single-center experience with systematic literature review and meta-analysis","volume":"12","author":"Hamada","year":"2021","journal-title":"Front Immunol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T06:14:37Z","timestamp":1727417677000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2024.12715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,9,11]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2024.12715","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"article-number":"426"}}